A study of Chinese-Western-Combined Therapy for AIDS to improve effect and decrease toxicity

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR-TRC-14004546

Enrollment

Unknown

Registered

2014-03-07

Start date

2014-05-21

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

AIDS

Interventions

Controlled groud:HAART

Treatment group:HAART

Eligibility

Sex/Gender

All

Age

18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Patient meet the Diagnostic Standard of AIDS, published by the Chinese Medical infectant diseases' Association in 2005. Patients aged 18-65 years and must sign informed consent.

Exclusion criteria

Exclusion criteria: insane, or cannot cooperate; participating other research nearly 3 month; pregnancy

Design outcomes

Primary

Measure	Time frame
Immunologic function-T lymphocyte subse;Blood;	—

Countries

China

Contacts

Public ContactXin Deng

Ruikang Affiliated Hospital of Guangxi University of Chinese Medicine

dx8848@126.com+86 13607884892

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026